'08 Walk for Life

* PICTURES FROM 2006 MARCH FOR LIFE *

Pregnancy Centers


Event Calendar
Research
Abstinence
FAQ's
Health Issues
Recent News
Public Policy
Alerts
Links
About Us
Volunteer
Donate

Home

     


Searle Warning Letter Concerning Use of Misoprostol in RU 486 Abortions

[Note: Following the FDA's approval of RU 486, the drug company Searle has objected to the use of an ulcer-treating drug (Cytotec) it makes being used as the second part of the abortion process involved with RU 486. The first step of RU 486 is a drug used to kill the unborn child and Cytotec (misoprostol) is then misused to induce a miscarriage of the aborted child. The following is the text of the Searle letter objecting to the misuse of their drug.]


August 23, 2000

Re: Cytotec (misoprostol)

IMPORTANT DRUG WARNING CONCERNING UNAPPROVED USE OF INTRAVAGINAL OR ORAL MISOPROSTOL IN PREGNANT WOMEN FOR INDUCTION OF LABOR OR ABORTION

Dear Health Care Provider:

The purpose of this letter is to remind you that Cytotec administration by any route is contraindicated in women who are pregnant because it can cause abortion. Cytotec is not approved for the induction of labor or abortion.

Cytotec is indicated for the prevention of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)-induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.

The uterotonic effect of Cytotec is an inherent property of prostaglandin E1(PGE1), of which Cytotec is stable, orally active, synthetic analog. Searle has become aware of some instances where Cytotec, outside of its approved indication, was used as a cervical ripening agent prior to termination of pregnancy, or for induction of labor, in spite of the specific contraindications to its use during pregnancy.

Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy or salpingo-oophorectomy; amniotic fluid embolism; severe vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain.

Searle has not conducted research concerning the use of Cytotec for cervical ripening prior to termination of pregnancy or for induction of labor, nor does Searle intend to study or support these uses. Therefore, Searle is unable to provide complete risk information for Cytotec when it is used for such purposes. In addition to the known and unknown acute risks to the mother and fetus, the effect of Cytotec on the later growth, development and functional maturation of the child when Cytotec is used for induction of labor or cervical ripening has not been established.

Searle promotes the use of Cytotec only for its approved indication. Please read the enclosed updated complete Prescribing Information for Cytotec.


Further information may be obtained by calling 1-800-323-4204.

Michael Cullen, MD
Medical Director, U.S.
Searle
5200 Old Orchard Road
Skokie, Illinois, 60077

Phone: (847) 982-7000

Fax: (847) 470-1480



Sources: Fox News, October 16, 2000, and Pro-life Infonet


Be a TLC Lifeguard

Before You Leave...
We hope you enjoy our web site and find it useful as a resource center. Please take a moment to rate our site.

Will you help?
Will you help us continue to make this resource available to thousands of monthly visitors from around the world? Yes


Texans for Life Coalition
P.O. Box 177727
Irving, TX 75017-7727
(972) 790-9044
webservant@texlife.org